Integrating MRI-PDFF and MR Elastography in MASLD: Technical Pitfalls, Discordant Findings, and Clinical Decision-Making

Authors

  • Jyoti Yadav
  • Shivanshu Chauhan
  • Ashish Kumar Shukla
  • Ranjeet Singh
  • Aarushi Sabharwal
  • Bharat Bhushan Dagur
  • Nitish Ranjan
  • Niharika Singh

Keywords:

MASLD; MASH; MRI-PDFF; magnetic resonance elastography; liver fibrosis; quantitative MRI; steatosis; discordant imaging findings.

Abstract

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a spectrum of hepatic abnormalities in which steatosis and fibrosis represent distinct but interrelated disease processes. Magnetic resonance imaging proton density fat fraction (MRI-PDFF) and magnetic resonance elastography (MRE) provide quantitative, non-invasive assessments of hepatic fat content and liver stiffness, respectively. However, their interpretation may be complicated by technical limitations, biological confounders, and discordant findings.

Objective: This review examines the technical foundations, clinical applications, interpretative challenges, and integration of MRI-PDFF and MRE for the assessment and longitudinal monitoring of MASLD.

Review approach: Relevant clinical practice guidelines, technical investigations, diagnostic validation studies, and clinical outcome studies were considered to synthesise evidence concerning acquisition methods, measurement reproducibility, confounding factors, treatment response, and clinical risk stratification.

Discussion: MRI-PDFF enables quantitative assessment of hepatic steatosis and monitoring of treatment-associated changes in liver fat, whereas MRE provides a sensitive biomarker of liver stiffness associated with fibrosis and adverse clinical outcomes. Neither technique independently establishes the complete histological diagnosis of metabolic dysfunction-associated steatohepatitis or confirms fibrosis regression. Discordance between imaging findings and other non-invasive tests may reflect differences in biological processes, inflammatory activity, technical adequacy, measurement variability, or examination timing. Integrating quantitative MRI with biochemical indices, including the Fibrosis-4 index, and validated composite scores may improve clinical risk characterisation. Standardised acquisition, appropriate quality control, and contextual interpretation remain essential.

Conclusion: Combining MRI-PDFF and MRE offers complementary information for MASLD assessment, treatment monitoring, and fibrosis-related risk stratification. Clinically validated interpretation frameworks and standardised protocols are needed to optimise their use within established clinical pathways.

Published

2026-11-16

How to Cite

Yadav, J., Chauhan, S., Shukla, A. K., Singh, R., Sabharwal, A., Dagur, B. B., … Singh, N. (2026). Integrating MRI-PDFF and MR Elastography in MASLD: Technical Pitfalls, Discordant Findings, and Clinical Decision-Making. Adolescência E Saúde, 315–329. Retrieved from https://adolescenciaesaude.com/index.php/aes/article/view/3293

Issue

Section

Original Articles